Pune, India — 01/12/2018 — Heart Transplantation has emerged as a viable therapeutic strategy for some patients with end-stage heart disease by offering them extended survival and improved quality of life. The cardiologist may refer the patient to a heart transplant center if, the patient health is serious and other treatments are not able to improve things or control patient symptoms. In a heart transplant, a surgery is performed to remove a person's diseased heart and replace it with a healthy heart from a deceased donor. Mostly, it is done on patients who have end-stage heart failure.
Coronary artery disease is the one of the main cause which damages the heart muscle that results in heart failure. There are many diseases which lead to heart failures such as cough-especially at night, poor exercise tolerance, shortness of breath, fatigue and fluid retention.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/1836 .
According to the registry of the International Society for Heart and Lung Transplantation, approximately 500-600 pediatric heart transplantation procedures are performed globally every year, which represents around 12% of the total number of heart transplants performed. And in 2014, a total number of children heart transplants execute globally was 586. In children, the most often caused of heart failure is occurred owing to a congenital heart defect or a cardiomyopathy.
World Heart Transplant Market/ Innovation/ Related News:
February 2017 – The University of Pittsburgh Medical Center and Microsoft announced their partnership launching an initiative to build three specialty hospitals with a digital focus. UPMC declared the investment of USD 2 billion to add three tech-based hospitals to its healthcare system in Pittsburgh, including the UPMC Heart and Transplant Hospital, UPMC Hillman Cancer Hospital and UPMC Vision and Rehabilitation Hospital. Microsoft will act as creative force for developing the digital hospitals in this collaboration providing developers and leveraging its digital tools.
November 2017 – Doctors at the Cleveland Clinic revealed the new understanding of cholesterol after a number of trials that have recently shown a 20 percent reduction in the risk of cardiovascular death, heart attack, and stroke in patients who took statins combined with a new class of cholesterol-lowering drugs (PCSK9 inhibitors) to reach ultra-low LDL levels. This means now, doctors will have the tools and the research to take the fight to LDL cholesterol. With over 400,000 coronary disease deaths and 102 million Americans living with high cholesterol levels, these new strategies hold the promise to turn the tide in 2018.
Global Heart Transplant Market Regional Analysis:
The Americas dominate the global heart transplant market owing to well-developed technology, high health care spending, increasing government support for research & development, and increasing patient with coronary artery disease, heart valve disease, and cardiomyopathy. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region. According to the International Society for Heart and Lung Transplantation in 2016, total heart transplants in the U.S. were performed in patients up to 17 years of age is 444.
Europe holds the second position in the global heart transplantation market owing to the government support for research & development and availability of funds for research. This is expected to continue driving the European market over the forecasted period. For instance, countries like Germany and France are increasing investment in the healthcare domain.
Asia Pacific is the fastest growing health transplantation market owing to the presence of rapidly developing healthcare technology and high healthcare expenditure. Moreover, lower treatment cost as compared to developed countries attract global patients to the countries like India and China market. Furthermore, increasing demand for quality devices in the healthcare is projected to lead to the use of advanced equipment, which, in turn, is likely to increase the growth of the heart transplantation market in the region.
On the other hand, the Middle East and Africa account for the least market owing to poor political conditions in Africa and limited availability of funds and medical facilities. The Middle East holds the major share of the Middle East & Africa region due to the presence of well-developed countries like Kuwait, Qatar, Oman, and South Arabia.
Heart Transplant Market Key Players:
Some of the key players in this market are SynCardia Systems, LLC (U.S.), HeartWare International Inc., Apaxis Medical, Inc., Calon Cardio, Optum Inc. (U.S.), Thoratec Corporation (U.S.), CardiacAssist Inc. (U.S.), CARMAT (France), and others.
Order a Single User Premium 80 Pages Copy Enabled with Tables and Figures is Available @ https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=1836 .
Major TOC Heart Transplant Market:
2. Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
3. Research Methodology
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
4. Market Dynamics
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/1836 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Powered by WPeMatico